Besides, higher serum and CSF NfL levels in patients with PD have been shown to correlate with longer disease duration, greater disease severity, and a higher risk of motor symptom progression (Lin et al., 2019; Mollenhauer et al., 2020; Oosterveld et al., 2020). Here, NEFL is linked to Parkinson disease.